Global Polypeptide Drug Sales Market Report 2021

1 Polypeptide Drug Market Overview

• 1.1 Polypeptide Drug Product Scope
• 1.2 Polypeptide Drug Segment by Type
  • 1.2.1 Global Polypeptide Drug Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Injection
  • 1.2.3 Nasal Administration
  • 1.2.4 Lung Administration
  • 1.2.5 Oral Administration
  • 1.2.6 Transdermal Administration
• 1.3 Polypeptide Drug Segment by Application
  • 1.3.1 Global Polypeptide Drug Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)
  • 1.3.3 Digestive System Drugs (Gastrointestinal Type)
  • 1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
  • 1.3.5 Gynecologic or Obstetric Drug
  • 1.3.6 Tumor Drug
  • 1.3.7 Urinary System Drug
  • 1.3.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
• 1.4 Polypeptide Drug Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Polypeptide Drug Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Polypeptide Drug Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Polypeptide Drug Price Trends (2016-2027)

2 Polypeptide Drug Estimates and Forecasts by Region

• 2.1 Global Polypeptide Drug Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Polypeptide Drug Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Polypeptide Drug Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Polypeptide Drug Revenue Market Share by Region (2016-2021)
• 2.3 Global Polypeptide Drug Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Polypeptide Drug Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Polypeptide Drug Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Polypeptide Drug Estimates and Projections (2016-2027)
  • 2.4.2 Europe Polypeptide Drug Estimates and Projections (2016-2027)
  • 2.4.3 China Polypeptide Drug Estimates and Projections (2016-2027)
  • 2.4.4 Japan Polypeptide Drug Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Polypeptide Drug Estimates and Projections (2016-2027)
  • 2.4.6 India Polypeptide Drug Estimates and Projections (2016-2027)

3 Global Polypeptide Drug Competition Landscape by Players

• 3.1 Global Top Polypeptide Drug Players by Sales (2016-2021)
• 3.2 Global Top Polypeptide Drug Players by Revenue (2016-2021)
• 3.3 Global Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Polypeptide Drug as of 2020)
• 3.4 Global Polypeptide Drug Average Price by Company (2016-2021)
• 3.5 Manufacturers Polypeptide Drug Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Polypeptide Drug Market Size by Type

• 4.1 Global Polypeptide Drug Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Polypeptide Drug Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Polypeptide Drug Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Polypeptide Drug Price by Type (2016-2021)
• 4.2 Global Polypeptide Drug Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Polypeptide Drug Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Polypeptide Drug Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Polypeptide Drug Price Forecast by Type (2022-2027)

5 Global Polypeptide Drug Market Size by Application

• 5.1 Global Polypeptide Drug Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Polypeptide Drug Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Polypeptide Drug Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Polypeptide Drug Price by Application (2016-2021)
• 5.2 Global Polypeptide Drug Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Polypeptide Drug Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Polypeptide Drug Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Polypeptide Drug Price Forecast by Application (2022-2027)

6 North America Polypeptide Drug Market Facts & Figures

• 6.1 North America Polypeptide Drug Sales by Company
  • 6.1.1 North America Polypeptide Drug Sales by Company (2016-2021)
  • 6.1.2 North America Polypeptide Drug Revenue by Company (2016-2021)
• 6.2 North America Polypeptide Drug Sales Breakdown by Type
  • 6.2.1 North America Polypeptide Drug Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Polypeptide Drug Sales Breakdown by Type (2022-2027)
• 6.3 North America Polypeptide Drug Sales Breakdown by Application
  • 6.3.1 North America Polypeptide Drug Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Polypeptide Drug Sales Breakdown by Application (2022-2027)

7 Europe Polypeptide Drug Market Facts & Figures

• 7.1 Europe Polypeptide Drug Sales by Company
  • 7.1.1 Europe Polypeptide Drug Sales by Company (2016-2021)
  • 7.1.2 Europe Polypeptide Drug Revenue by Company (2016-2021)
• 7.2 Europe Polypeptide Drug Sales Breakdown by Type
  • 7.2.1 Europe Polypeptide Drug Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Polypeptide Drug Sales Breakdown by Type (2022-2027)
• 7.3 Europe Polypeptide Drug Sales Breakdown by Application
  • 7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)

8 China Polypeptide Drug Market Facts & Figures

• 8.1 China Polypeptide Drug Sales by Company
  • 8.1.1 China Polypeptide Drug Sales by Company (2016-2021)
  • 8.1.2 China Polypeptide Drug Revenue by Company (2016-2021)
• 8.2 China Polypeptide Drug Sales Breakdown by Type
  • 8.2.1 China Polypeptide Drug Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Polypeptide Drug Sales Breakdown by Type (2022-2027)
• 8.3 China Polypeptide Drug Sales Breakdown by Application
  • 8.3.1 China 156 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 156 Sales Breakdown by Application (2022-2027)

9 Japan Polypeptide Drug Market Facts & Figures

• 9.1 Japan Polypeptide Drug Sales by Company
  • 9.1.1 Japan Polypeptide Drug Sales by Company (2016-2021)
  • 9.1.2 Japan Polypeptide Drug Revenue by Company (2016-2021)
• 9.2 Japan Polypeptide Drug Sales Breakdown by Type
  • 9.2.1 Japan Polypeptide Drug Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Polypeptide Drug Sales Breakdown by Type (2022-2027)
• 9.3 Japan Polypeptide Drug Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Polypeptide Drug Market Facts & Figures

• 10.1 Southeast Asia Polypeptide Drug Sales by Company
  • 10.1.1 Southeast Asia Polypeptide Drug Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Polypeptide Drug Revenue by Company (2016-2021)
• 10.2 Southeast Asia Polypeptide Drug Sales Breakdown by Type
  • 10.2.1 Southeast Asia Polypeptide Drug Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Polypeptide Drug Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Polypeptide Drug Sales Breakdown by Application
  • 10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)

11 India Polypeptide Drug Market Facts & Figures

• 11.1 India Polypeptide Drug Sales by Company
  • 11.1.1 India Polypeptide Drug Sales by Company (2016-2021)
  • 11.1.2 India Polypeptide Drug Revenue by Company (2016-2021)
• 11.2 India Polypeptide Drug Sales Breakdown by Type
  • 11.2.1 India Polypeptide Drug Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Polypeptide Drug Sales Breakdown by Type (2022-2027)
• 11.3 India Polypeptide Drug Sales Breakdown by Application
  • 11.3.1 India Polypeptide Drug Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Polypeptide Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Polypeptide Drug Business

• 12.1 Novartis
  • 12.1.1 Novartis Corporation Information
  • 12.1.2 Novartis Business Overview
  • 12.1.3 Novartis Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Novartis Polypeptide Drug Products Offered
  • 12.1.5 Novartis Recent Development
• 12.2 Merck Serono
  • 12.2.1 Merck Serono Corporation Information
  • 12.2.2 Merck Serono Business Overview
  • 12.2.3 Merck Serono Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Merck Serono Polypeptide Drug Products Offered
  • 12.2.5 Merck Serono Recent Development
• 12.3 Ferring Pharmaceuticals
  • 12.3.1 Ferring Pharmaceuticals Corporation Information
  • 12.3.2 Ferring Pharmaceuticals Business Overview
  • 12.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Ferring Pharmaceuticals Polypeptide Drug Products Offered
  • 12.3.5 Ferring Pharmaceuticals Recent Development
• 12.4 Ipsen PHarma Biotech
  • 12.4.1 Ipsen PHarma Biotech Corporation Information
  • 12.4.2 Ipsen PHarma Biotech Business Overview
  • 12.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Ipsen PHarma Biotech Polypeptide Drug Products Offered
  • 12.4.5 Ipsen PHarma Biotech Recent Development
• 12.5 Lilly
  • 12.5.1 Lilly Corporation Information
  • 12.5.2 Lilly Business Overview
  • 12.5.3 Lilly Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Lilly Polypeptide Drug Products Offered
  • 12.5.5 Lilly Recent Development
• 12.6 Asahi Kasei
  • 12.6.1 Asahi Kasei Corporation Information
  • 12.6.2 Asahi Kasei Business Overview
  • 12.6.3 Asahi Kasei Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Asahi Kasei Polypeptide Drug Products Offered
  • 12.6.5 Asahi Kasei Recent Development
• 12.7 AstraZeneca
  • 12.7.1 AstraZeneca Corporation Information
  • 12.7.2 AstraZeneca Business Overview
  • 12.7.3 AstraZeneca Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 AstraZeneca Polypeptide Drug Products Offered
  • 12.7.5 AstraZeneca Recent Development
• 12.8 SciClone Pharmaceuticals
  • 12.8.1 SciClone Pharmaceuticals Corporation Information
  • 12.8.2 SciClone Pharmaceuticals Business Overview
  • 12.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 SciClone Pharmaceuticals Polypeptide Drug Products Offered
  • 12.8.5 SciClone Pharmaceuticals Recent Development
• 12.9 Takeda
  • 12.9.1 Takeda Corporation Information
  • 12.9.2 Takeda Business Overview
  • 12.9.3 Takeda Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Takeda Polypeptide Drug Products Offered
  • 12.9.5 Takeda Recent Development
• 12.10 Roche
  • 12.10.1 Roche Corporation Information
  • 12.10.2 Roche Business Overview
  • 12.10.3 Roche Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Roche Polypeptide Drug Products Offered
  • 12.10.5 Roche Recent Development
• 12.11 Sanofi
  • 12.11.1 Sanofi Corporation Information
  • 12.11.2 Sanofi Business Overview
  • 12.11.3 Sanofi Polypeptide Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Sanofi Polypeptide Drug Products Offered
  • 12.11.5 Sanofi Recent Development

13 Polypeptide Drug Manufacturing Cost Analysis

• 13.1 Polypeptide Drug Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Polypeptide Drug
• 13.4 Polypeptide Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Polypeptide Drug Distributors List
• 14.3 Polypeptide Drug Customers

15 Market Dynamics

• 15.1 Polypeptide Drug Market Trends
• 15.2 Polypeptide Drug Drivers
• 15.3 Polypeptide Drug Market Challenges
• 15.4 Polypeptide Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List